Literature DB >> 31624008

Expressive writing - Who is it good for? Individual differences in the improvement of mental health resulting from expressive writing.

Daphna Sabo Mordechay1, Bracha Nir2, Zohar Eviatar3.   

Abstract

OBJECTIVE: we examined individual differences in the effects of expressive writing. We hypothesized that moderate levels of neuroticism, low levels of experiential avoidance, and highly rated subjective severity would be linked to greater change in well-being post-writing.
DESIGN: participants were randomly assigned to the expressive group (N = 104) who wrote about emotion-laden experiences, or the control group (N = 51) who wrote about everyday events. All completed the IES and BSI pre and 1, 3, and 6 weeks post-writing.
RESULTS: overall, we replicated the seminal result, with greater reductions in IES scores in the expressive writing group. In addition, in the expressive group, as expected, participants with higher severity scores had greater reductions in BSI scores. Surprisingly, individuals with high rather than moderate neuroticism and high rather than low experiential avoidance scores also experienced more benefit.
CONCLUSIONS: participants who are more aware of, in touch with, and suffer more from negative feelings are those who gain the most from expressive writing. Based on this conclusion, clinical implications relevant to both psychotherapy patients and non-patients are suggested.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Experiential avoidance; Expressive writing; Individual differences; Neuroticism; Severity; Well-being

Mesh:

Year:  2019        PMID: 31624008     DOI: 10.1016/j.ctcp.2019.101064

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  1 in total

1.  Effectiveness of Expressive Writing in the Reduction of Psychological Distress During the COVID-19 Pandemic: A Randomized Controlled Trial.

Authors:  Maša Vukčević Marković; Jovana Bjekić; Stefan Priebe
Journal:  Front Psychol       Date:  2020-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.